Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Godwin Yung

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Statistics in Biopharmaceutical Research|June 30, 2021
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand FrameworkEvgeny Degtyarev, Kaspar Rufibach, Yue Shentu, et al.
Leukemia|March 24, 2018
Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1Laurent Garderet, Jacob P Laubach, Anne-Marie Stoppa, et al.
Pharmaceutical Statistics|October 4, 2021
Estimands for overall survival in clinical trials with treatment switching in oncologyJuliane Manitz, Natalia Kan-Dobrosky, Hannes Buchner, et al.
Scientific Reports|July 25, 2015
Novel structural co-expression analysis linking the NPM1-associated ribosomal biogenesis network to chronic myelogenous leukemiaLawrence W C Chan, Xihong Lin, Godwin Yung, et al.
Blood|March 25, 2021
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myelomaThierry Facon, Christopher P Venner, Nizar J Bahlis, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Statistics in Biopharmaceutical Research|June 30, 2021
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand FrameworkEvgeny Degtyarev, Kaspar Rufibach, Yue Shentu, et al.
Leukemia|March 24, 2018
Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1Laurent Garderet, Jacob P Laubach, Anne-Marie Stoppa, et al.
Pharmaceutical Statistics|October 4, 2021
Estimands for overall survival in clinical trials with treatment switching in oncologyJuliane Manitz, Natalia Kan-Dobrosky, Hannes Buchner, et al.
Scientific Reports|July 25, 2015
Novel structural co-expression analysis linking the NPM1-associated ribosomal biogenesis network to chronic myelogenous leukemiaLawrence W C Chan, Xihong Lin, Godwin Yung, et al.
Blood|March 25, 2021
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myelomaThierry Facon, Christopher P Venner, Nizar J Bahlis, et al.
Pageof 2